Drug Trial Radar · NCT07776522
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Aug 31, 2026
Primary completion
Aug 15, 2027
Study completion Jan 14, 2032
Sponsor
- Lead sponsor
- West China HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II, randomized, open-label, active-controlled study designed to evaluate the preliminary efficacy and safety of a single subretinal administration of JWK001 at different dose levels in patients with neovascular age-related macular degeneration.
Conditions
- Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Interventions
JWK001Drug
JWK001 will be administered as a single subretinal injection in one study eye.
Aflibercept (2.0 mg)Drug
Aflibercept 2 mg will be administered by intravitreal injection at Weeks 2, 10, 18, 26, 34, 42, and 50 after randomization, for a total of seven injections.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in best-corrected visual acuity (BCVA)Time frame: Week 34
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Beijing Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
The Second Hospital of Jilin University
Jilin City, Changchun, China · Not yet recruiting
Southwest Hospital, Army Medical University(Southwest Hospital)
Chongqing, Chongqing Municipality, China · Not yet recruiting
Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong
Shantou, Guangdong, China · Not yet recruiting
Zhejiang Provincial People's Hospital
Zhejiang, Hangzhou, China · Not yet recruiting
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Not yet recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Not yet recruiting
General Hospital of Central Theater Command, Chinese People's Liberation Army
Wuhan, Hubei, China · Not yet recruiting
Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China · Not yet recruiting
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China · Not yet recruiting
Shanxi Bethune Hospital
Taiyuan, Shanxi, China · Not yet recruiting
Shanxi Eye Hospital
Taiyuan, Shanxi, China · Not yet recruiting
West China Hospital, Sichuan University
Chengdu, Sichuan, China · Recruiting
Tianjin Eye Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
The First People's Hospital of Yunnan Province
Kunming, Yunnan, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.